LABP
Landos Biopharma, Inc. Common Stock
LABP
LABP
Delisted
LABP was delisted on the 23rd of May, 2024.
40 hedge funds and large institutions have $120M invested in Landos Biopharma, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
64% less capital invested
Capital invested by funds: $331M → $120M (-$211M)
Holders
40
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.14M | |
| 2 | +$769K | |
| 3 | +$730K | |
| 4 |
Walleye Capital
New York
|
+$505K |
| 5 |
Two Sigma Investments
New York
|
+$263K |
Top Sellers
| 1 | -$3.11M | |
| 2 | -$1.82M | |
| 3 | -$275K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$265K |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$144K |